Establishing a transnational advanced pilot manufacturing ecosystem for future biomedical products
|Priority||1. Stimulating innovation and competitiveness|
|Objective||1.1. Enhancing innovation capacity through corporation to foster competitiveness|
Lead partner:National University of Ireland Galway
|ERDF funding||2.075.280,34 €|
|Total budget||2.767.040,46 €|
|Duration||2017-11-01 - 2020-10-31|
Currently there is no biomaterials pilot manufacturing ecosystem for translating concepts from the research-bench to pilot production readily accessible for SMEs + micro-enterprises within the Atlantic Area.
The objective of Atlantic-Ket-Med is to create new innovation capacity by establishing an inter-regional pilot manufacturing ecosystem, developing human and infrastructural resources. The project will use the biomedical sector as a driver in the near term. In the longer term, it will help to establish productive systems for extracting greater value from the Atlantic biomaterials.
In terms of impact, partners and recruited SMEs + micro-enterprises will learn best practice in innovation and competition through: the implementation of audits and analyses of technical value chains, respectively; audits will inform transnational partnerships in which inter-regional innovation capacity is to be developed; differentiated value chains will determine sustainable competitiveness for enterprises; gaps in value chains will determine priority for development of innovation capacities; new training and expertise in key enabling technologies, Industrie 4.0 and Scalable Innovation, facilitated by three workshops, will underpin the use of transnational pilot system components. Finally, it will also be developed access procedures for 25 separate processes in the pilot ecosystem and five case studies will demonstrate opportunities for pilot manufacturing.
National University of Ireland Galway
|Border, Midland and Western (IE)|
International Iberian Nanotechnology Laboratory
Fundación para a Investigación, o Desenvolvemento e a Innovación Ramón Domínguez,
Centre of Excellence for Life Sciences Ltd. trading as Bionow
|Greater Manchester (UK)|
Science and Technology Facilities Council